These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1106278)

  • 1. Cyclophosphamide or azathioprine in lupus glomerulonephritis. A controlled trial: results at 28 months.
    Decker JL; Klippel JH; Plotz PH; Steinberg AD
    Ann Intern Med; 1975 Nov; 83(5):606-15. PubMed ID: 1106278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prednisone and azathioprine compared to prednisone plus low-dose azathioprine and cyclophosphamide in the treatment of diffuse lupus nephritis.
    Ginzler E; Diamond H; Guttadauria M; Kaplan D
    Arthritis Rheum; 1976; 19(4):693-9. PubMed ID: 782464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.
    Austin HA; Klippel JH; Balow JE; le Riche NG; Steinberg AD; Plotz PH; Decker JL
    N Engl J Med; 1986 Mar; 314(10):614-9. PubMed ID: 3511372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic drug treatment of lupus nephritis.
    Donadio JV; Holley KE; Ilstrup DM
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis.
    Dinant HJ; Decker JL; Klippel JH; Balow JE; Plotz PH; Steinberg AD
    Ann Intern Med; 1982 Jun; 96(6 Pt 1):728-36. PubMed ID: 7046543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis.
    Steinberg AD; Decker JL
    Arthritis Rheum; 1974; 17(6):923-37. PubMed ID: 4611431
    [No Abstract]   [Full Text] [Related]  

  • 7. Longterm survival of lupus nephritis patients treated with azathioprine and prednisone.
    Barnett EV; Dornfeld L; Lee DB; Liebling MR
    J Rheumatol; 1978; 5(3):275-87. PubMed ID: 372523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled studies of oral immunosuppressive drugs in lupus nephritis. A long-term follow-up.
    Carette S; Klippel JH; Decker JL; Austin HA; Plotz PH; Steinberg AD; Balow JE
    Ann Intern Med; 1983 Jul; 99(1):1-8. PubMed ID: 6344715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive agents in lupus nephritis: a critical analysis.
    Wagner L
    Medicine (Baltimore); 1976 May; 55(3):239-50. PubMed ID: 775253
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. Results of a pooled analysis.
    Felson DT; Anderson J
    N Engl J Med; 1984 Dec; 311(24):1528-33. PubMed ID: 6390198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus nephritis: clinical course in relation to treatment.
    Nanra RS; Kincaid-Smith P
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1193-210. PubMed ID: 4803309
    [No Abstract]   [Full Text] [Related]  

  • 12. Azathioprine in steroid-insensitive nephropathy.
    Bardana EJ; Porter GA; Pirofsky B; Gourley RT; Bayrakci C
    Am J Med; 1970 Dec; 49(6):789-800. PubMed ID: 5006617
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of chlorambucil, azathioprine or cyclophosphamide combined with corticosteroids in the treatment of lupus nephritis.
    Sabbour MS; Osman LM
    Br J Dermatol; 1979 Feb; 100(2):113-25. PubMed ID: 85455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression from minimal or focal to diffuse proliferative lupus nephritis.
    Zimmerman SW; Jenkins PG; Shelf WD; Bloodworth JM; Burkholder PM
    Lab Invest; 1975 May; 32(5):665-72. PubMed ID: 1092911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopathology in systemic lupus erythematosus. II. Relation to clinical observations, corticosteroid administration, and cerebrospinal fluid C4.
    Baker M; Hadler NM; Whitaker JN; Dunner DL; Gerwin RD; Decker JL
    Semin Arthritis Rheum; 1973; 3(2):111-26. PubMed ID: 4584527
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of azathioprine on lupus glomerulonephritis.
    Hayslett JP; Kashgarian M; Cook CD; Spargo BH
    Medicine (Baltimore); 1972 Sep; 51(5):393-412. PubMed ID: 4115512
    [No Abstract]   [Full Text] [Related]  

  • 18. [Course of nephropathy in systemic lupus erythematosus . Influence of the treatment on clinical symptoms, renal function and histology].
    Zech P; Richard P; Blanc-Brunat N; Labeeuw M; Colon S; Pozet N; Dupont E; Fries D; Traeger J
    J Urol Nephrol (Paris); 1972 Dec; 78(12):987-93. PubMed ID: 4540960
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of primary chronic glomerulonephritis with a triple combination of prednisone, azathioprine and a nitrogen mustard derivative].
    Traver JA; Guajardo DS; Botella J
    Rev Clin Esp; 1975 May; 137(4):321-5. PubMed ID: 1144863
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment with immunosuppressive agents in disseminated lupus erythematosus and in some evolutive nephropathies].
    Purice S; Ghelerter L; Matei I; Brunazian G
    Stud Cercet Med Interna; 1969; 10(2):147-53. PubMed ID: 5344004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.